Adjunctive gabapentin for treatment-resistant insomnia of bipolar disorder: A case report

Clinical Neuropharmacology

Volumn 34, Issue 3, 2011, Pages 129-130

  Egashira, Toshiaki ^a,b   Inoue, Takeshi ^a   Shirai, Yasuyuki ^b   Iwata, Kazuya ^b   Honma, Jiro ^b   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Wakkanai City Hospital   (Japan)

Author keywords

bipolar disorder; Gabapentin; refractory insomnia

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BROMISOVAL; CARBAMAZEPINE; DIAZEPAM; ESTAZOLAM; GABAPENTIN; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; QUETIAPINE; RISPERIDONE; TRIAZOLAM; VALPROIC ACID; ZOTEPINE;

ADJUVANT THERAPY; ADULT; ANXIETY; AROUSAL; ARTICLE; BEDTIME DOSAGE; BIPOLAR DISORDER; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; IMPULSIVENESS; INSOMNIA; MALE; MIXED MANIA AND DEPRESSION; PRIORITY JOURNAL; SLEEP WAKING CYCLE; TREATMENT RESPONSE;

ADULT; AMINES; BIPOLAR DISORDER; CYCLOHEXANECARBOXYLIC ACIDS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 79959260354     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0b013e318213b9cd     Document Type: Article

References (11)

1. Harvey AG. Sleep and circadian rhythms in bipolar disorder: seeking synchrony, harmony, and regulation. Am J Psychiatry 2008;165:820-829. (Pubitemid 351948714)
2. Kusumi I, Ohmori T, Kohsaka M, et al. Chronobiological approach for treatment-resistant rapid cycling affective disorders. Biol Psychiatry 1995;37:553-559.
3. Foldvary-Schaefer N, De Leon Sanchez I, Karafa M, et al. Gabapentin increases slow-wave sleep in normal adults. Epilepsia 2002;43:1493-1497. (Pubitemid 35429766)
4. Lo HS, Yang CM, Lo HG, et al. Treatment effects of gabapentin for primary insomnia. Clin Neuropharmacol 2010;33:84-90.
5. Legros B, Bazil CW. Effects of antiepileptic drugs on sleep architecture: a pilot study. Sleep Med 2003;4:51-55. (Pubitemid 36284876)
6. Inagaki A, Inada T. Dose equivalence of psychotropic drugs. Part XVIII 2006 version [in Japanese]. Jpn J Clin Psychopharmacol 2006;9:1443-1447.
7. Fink K, Meder W, Dooley DJ, et al. Inhibition of neuronal Ca2+ influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br J Pharmacol 2000;130:900-906. (Pubitemid 30389071)
8. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 2009;11:225-255.
9. Vigo DV, Baldessarini RJ. Anticonvulsants in the treatment of major depressive disorder: an overview. Harv Rev Psychiatry 2009;17:231-241.
10. Vieta E, Manuel Goikolea J, Martinez-Aran A, et al. A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder. J Clin Psychiatry 2006;67:473-477.
11. Salinsky MC, Storzbach D, Spencer DC, et al. Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology 2005;64:792-798. (Pubitemid 40316314)